866-997-4948(US-Canada Toll Free)

Hemoglobinopathies Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Sep 2017

Category :

Pharmaceutical

No. of Pages : 53 Pages

Hemoglobinopathies Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Hemoglobinopathies Global Clinical Trials Review, H2, 2017" provides an overview of Hemoglobinopathies clinical trials scenario. This report provides top line data relating to the clinical trials on Hemoglobinopathies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Hemoglobinopathies to Hematological Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Hemoglobinopathies Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Source 53

List of Tables
Hemoglobinopathies Therapeutics, Global, Clinical Trials by Region, 2017* 6
Hemoglobinopathies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Hemoglobinopathies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Hemoglobinopathies Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
Hemoglobinopathies Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Hemoglobinopathies Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Hemoglobinopathies Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Proportion of Hemoglobinopathies to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 14
Hemoglobinopathies Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Hemoglobinopathies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Hemoglobinopathies Therapeutics, Global, Clinical Trials by Phase, 2017* 17
Hemoglobinopathies Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 18
Hemoglobinopathies Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
Hemoglobinopathies Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
Hemoglobinopathies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
Hemoglobinopathies Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 22
Hemoglobinopathies Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
Hemoglobinopathies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
Hemoglobinopathies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25

List of Figures
Hemoglobinopathies Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Hemoglobinopathies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Hemoglobinopathies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Hemoglobinopathies Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
Hemoglobinopathies Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Hemoglobinopathies Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Proportion of Hemoglobinopathies to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 14
Hemoglobinopathies Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Hemoglobinopathies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Hemoglobinopathies Therapeutics, Global, Clinical Trials by Phase (%), 2017* 17
Hemoglobinopathies Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 18
Hemoglobinopathies Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
Hemoglobinopathies Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
Hemoglobinopathies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
Hemoglobinopathies Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 22
Hemoglobinopathies Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
Hemoglobinopathies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
Hemoglobinopathies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25
GlobalData Methodology 52

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *